← 產業報告目錄
OTC Anti-Infective Medications Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 115報告編號 APO-c8c39d9246
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global OTC Anti-Infective Medications market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the OTC Anti-Infective Medications market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the OTC Anti-Infective Medications market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the OTC Anti-Infective Medications market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of OTC Anti-Infective Medications include Abbott, Sanofi, Novartis, Merck, Roche, Pfizer, GlaxoSmithKline, Optimer Pharmaceuticals and Novabay Pharmaceuticals, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global OTC Anti-Infective Medications market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to OTC Anti-Infective Medications.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
OTC Anti-Infective Medications Market by Company
Abbott
Sanofi
Novartis
Merck
Roche
Pfizer
GlaxoSmithKline
Optimer Pharmaceuticals
Novabay Pharmaceuticals
NanoViricides
MerLion Pharma
Bristol-Myers Squibb
Basilea Pharmaceutica
OTC Anti-Infective Medications Segment by Type
Antiseptic
Antiparasitics
Antifungals
OTC Anti-Infective Medications Segment by Application
E-Commerce
Drug Stores
Hospital Pharmacies
OTC Anti-Infective Medications Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Anti-Infective Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of OTC Anti-Infective Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Anti-Infective Medications.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of OTC Anti-Infective Medications companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 OTC Anti-Infective Medications by Type
2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
2.2.2 Antiseptic
2.2.3 Antiparasitics
2.2.4 Antifungals
2.3 OTC Anti-Infective Medications by Application
2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.3.2 E-Commerce
2.3.3 Drug Stores
2.3.4 Hospital Pharmacies
2.4 Assumptions and Limitations
3 OTC Anti-Infective Medications Breakdown Data by Type
3.1 Global OTC Anti-Infective Medications Historic Market Size by Type (2021-2026)
3.2 Global OTC Anti-Infective Medications Forecasted Market Size by Type (2027-2032)
4 OTC Anti-Infective Medications Breakdown Data by Application
4.1 Global OTC Anti-Infective Medications Historic Market Size by Application (2021-2026)
4.2 Global OTC Anti-Infective Medications Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
5.1 Global OTC Anti-Infective Medications Market Perspective (2021-2032)
5.2 Global OTC Anti-Infective Medications Growth Trends by Region
5.2.1 Global OTC Anti-Infective Medications Market Size by Region: 2021 VS 2025 VS 2032
5.2.2 OTC Anti-Infective Medications Historic Market Size by Region (2021-2026)
5.2.3 OTC Anti-Infective Medications Forecasted Market Size by Region (2027-2032)
5.3 OTC Anti-Infective Medications Market Dynamics
5.3.1 OTC Anti-Infective Medications Industry Trends
5.3.2 OTC Anti-Infective Medications Market Drivers
5.3.3 OTC Anti-Infective Medications Market Challenges
5.3.4 OTC Anti-Infective Medications Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top OTC Anti-Infective Medications Players by Revenue
6.1.1 Global Top OTC Anti-Infective Medications Players by Revenue (2021-2026)
6.1.2 Global OTC Anti-Infective Medications Revenue Market Share by Players (2021-2026)
6.2 Global OTC Anti-Infective Medications Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of OTC Anti-Infective Medications Head Office and Area Served
6.4 Global OTC Anti-Infective Medications Players, Product Type & Application
6.5 Global OTC Anti-Infective Medications Manufacturers Established Date
6.6 Global OTC Anti-Infective Medications Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America OTC Anti-Infective Medications Market Size (2021-2032)
7.2 North America OTC Anti-Infective Medications Market Growth Rate by Country: 2021 VS 2025 VS 2032
7.3 North America OTC Anti-Infective Medications Market Size by Country (2021-2026)
7.4 North America OTC Anti-Infective Medications Market Size by Country (2027-2032)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe OTC Anti-Infective Medications Market Size (2021-2032)
8.2 Europe OTC Anti-Infective Medications Market Growth Rate by Country: 2021 VS 2025 VS 2032
8.3 Europe OTC Anti-Infective Medications Market Size by Country (2021-2026)
8.4 Europe OTC Anti-Infective Medications Market Size by Country (2027-2032)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific OTC Anti-Infective Medications Market Size (2021-2032)
9.2 Asia-Pacific OTC Anti-Infective Medications Market Growth Rate by Country: 2021 VS 2025 VS 2032
9.3 Asia-Pacific OTC Anti-Infective Medications Market Size by Country (2021-2026)
9.4 Asia-Pacific OTC Anti-Infective Medications Market Size by Country (2027-2032)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America OTC Anti-Infective Medications Market Size (2021-2032)
10.2 South America OTC Anti-Infective Medications Market Growth Rate by Country: 2021 VS 2025 VS 2032
10.3 South America OTC Anti-Infective Medications Market Size by Country (2021-2026)
10.4 South America OTC Anti-Infective Medications Market Size by Country (2027-2032)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa OTC Anti-Infective Medications Market Size (2021-2032)
11.2 Middle East & Africa OTC Anti-Infective Medications Market Growth Rate by Country: 2021 VS 2025 VS 2032
11.3 Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2021-2026)
11.4 Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2027-2032)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Abbott
12.1.1 Abbott Company Information
12.1.2 Abbott Business Overview
12.1.3 Abbott Revenue in OTC Anti-Infective Medications Business (2021-2026)
12.1.4 Abbott OTC Anti-Infective Medications Product Portfolio
12.1.5 Abbott Recent Developments
12.2 Sanofi
12.2.1 Sanofi Company Information
12.2.2 Sanofi Business Overview
12.2.3 Sanofi Revenue in OTC Anti-Infective Medications Business (2021-2026)
12.2.4 Sanofi OTC Anti-Infective Medications Product Portfolio
12.2.5 Sanofi Recent Developments
12.3 Novartis
12.3.1 Novartis Company Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Revenue in OTC Anti-Infective Medications Business (2021-2026)
12.3.4 Novartis OTC Anti-Infective Medications Product Portfolio
12.3.5 Novartis Recent Developments
12.4 Merck
12.4.1 Merck Company Information
12.4.2 Merck Business Overview
12.4.3 Merck Revenue in OTC Anti-Infective Medications Business (2021-2026)
12.4.4 Merck OTC Anti-Infective Medications Product Portfolio
12.4.5 Merck Recent Developments
12.5 Roche
12.5.1 Roche Company Information
12.5.2 Roche Business Overview
12.5.3 Roche Revenue in OTC Anti-Infective Medications Business (2021-2026)
12.5.4 Roche OTC Anti-Infective Medications Product Portfolio
12.5.5 Roche Recent Developments
12.6 Pfizer
12.6.1 Pfizer Company Information
12.6.2 Pfizer Business Overview
12.6.3 Pfizer Revenue in OTC Anti-Infective Medications Business (2021-2026)
12.6.4 Pfizer OTC Anti-Infective Medications Product Portfolio
12.6.5 Pfizer Recent Developments
12.7 GlaxoSmithKline
12.7.1 GlaxoSmithKline Company Information
12.7.2 GlaxoSmithKline Business Overview
12.7.3 GlaxoSmithKline Revenue in OTC Anti-Infective Medications Business (2021-2026)
12.7.4 GlaxoSmithKline OTC Anti-Infective Medications Product Portfolio
12.7.5 GlaxoSmithKline Recent Developments
12.8 Optimer Pharmaceuticals
12.8.1 Optimer Pharmaceuticals Company Information
12.8.2 Optimer Pharmaceuticals Business Overview
12.8.3 Optimer Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2021-2026)
12.8.4 Optimer Pharmaceuticals OTC Anti-Infective Medications Product Portfolio
12.8.5 Optimer Pharmaceuticals Recent Developments
12.9 Novabay Pharmaceuticals
12.9.1 Novabay Pharmaceuticals Company Information
12.9.2 Novabay Pharmaceuticals Business Overview
12.9.3 Novabay Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2021-2026)
12.9.4 Novabay Pharmaceuticals OTC Anti-Infective Medications Product Portfolio
12.9.5 Novabay Pharmaceuticals Recent Developments
12.10 NanoViricides
12.10.1 NanoViricides Company Information
12.10.2 NanoViricides Business Overview
12.10.3 NanoViricides Revenue in OTC Anti-Infective Medications Business (2021-2026)
12.10.4 NanoViricides OTC Anti-Infective Medications Product Portfolio
12.10.5 NanoViricides Recent Developments
12.11 MerLion Pharma
12.11.1 MerLion Pharma Company Information
12.11.2 MerLion Pharma Business Overview
12.11.3 MerLion Pharma Revenue in OTC Anti-Infective Medications Business (2021-2026)
12.11.4 MerLion Pharma OTC Anti-Infective Medications Product Portfolio
12.11.5 MerLion Pharma Recent Developments
12.12 Bristol-Myers Squibb
12.12.1 Bristol-Myers Squibb Company Information
12.12.2 Bristol-Myers Squibb Business Overview
12.12.3 Bristol-Myers Squibb Revenue in OTC Anti-Infective Medications Business (2021-2026)
12.12.4 Bristol-Myers Squibb OTC Anti-Infective Medications Product Portfolio
12.12.5 Bristol-Myers Squibb Recent Developments
12.13 Basilea Pharmaceutica
12.13.1 Basilea Pharmaceutica Company Information
12.13.2 Basilea Pharmaceutica Business Overview
12.13.3 Basilea Pharmaceutica Revenue in OTC Anti-Infective Medications Business (2021-2026)
12.13.4 Basilea Pharmaceutica OTC Anti-Infective Medications Product Portfolio
12.13.5 Basilea Pharmaceutica Recent Developments
13 Report Conclusion
14 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global OTC Anti-Infective Medications Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global OTC Anti-Infective Medications Revenue Market Share by Type (2021-2026)
Table 7. Global OTC Anti-Infective Medications Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global OTC Anti-Infective Medications Revenue Market Share by Type (2027-2032)
Table 9. Global OTC Anti-Infective Medications Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global OTC Anti-Infective Medications Revenue Market Share by Application (2021-2026)
Table 11. Global OTC Anti-Infective Medications Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global OTC Anti-Infective Medications Revenue Market Share by Application (2027-2032)
Table 13. Global OTC Anti-Infective Medications Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global OTC Anti-Infective Medications Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global OTC Anti-Infective Medications Market Share by Region (2021-2026)
Table 16. Global OTC Anti-Infective Medications Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global OTC Anti-Infective Medications Market Share by Region (2027-2032)
Table 18. OTC Anti-Infective Medications Industry Trends
Table 19. OTC Anti-Infective Medications Industry Drivers
Table 20. OTC Anti-Infective Medications Industry Opportunities and Challenges
Table 21. OTC Anti-Infective Medications Market Restraints
Table 22. Global Top OTC Anti-Infective Medications Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global OTC Anti-Infective Medications Revenue Market Share by Players (2021-2026)
Table 24. Global OTC Anti-Infective Medications Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of OTC Anti-Infective Medications, Headquarters and Area Served
Table 26. Global OTC Anti-Infective Medications Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global OTC Anti-Infective Medications by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America OTC Anti-Infective Medications Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America OTC Anti-Infective Medications Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America OTC Anti-Infective Medications Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe OTC Anti-Infective Medications Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe OTC Anti-Infective Medications Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe OTC Anti-Infective Medications Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific OTC Anti-Infective Medications Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific OTC Anti-Infective Medications Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific OTC Anti-Infective Medications Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America OTC Anti-Infective Medications Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America OTC Anti-Infective Medications Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America OTC Anti-Infective Medications Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa OTC Anti-Infective Medications Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2027-2032) & (US$ Million)
Table 45. Abbott Company Information
Table 46. Abbott Business Overview
Table 47. Abbott Revenue in OTC Anti-Infective Medications Business (2021-2026) & (US$ Million)
Table 48. Abbott OTC Anti-Infective Medications Product Portfolio
Table 49. Abbott Recent Developments
Table 50. Sanofi Company Information
Table 51. Sanofi Business Overview
Table 52. Sanofi Revenue in OTC Anti-Infective Medications Business (2021-2026) & (US$ Million)
Table 53. Sanofi OTC Anti-Infective Medications Product Portfolio
Table 54. Sanofi Recent Developments
Table 55. Novartis Company Information
Table 56. Novartis Business Overview
Table 57. Novartis Revenue in OTC Anti-Infective Medications Business (2021-2026) & (US$ Million)
Table 58. Novartis OTC Anti-Infective Medications Product Portfolio
Table 59. Novartis Recent Developments
Table 60. Merck Company Information
Table 61. Merck Business Overview
Table 62. Merck Revenue in OTC Anti-Infective Medications Business (2021-2026) & (US$ Million)
Table 63. Merck OTC Anti-Infective Medications Product Portfolio
Table 64. Merck Recent Developments
Table 65. Roche Company Information
Table 66. Roche Business Overview
Table 67. Roche Revenue in OTC Anti-Infective Medications Business (2021-2026) & (US$ Million)
Table 68. Roche OTC Anti-Infective Medications Product Portfolio
Table 69. Roche Recent Developments
Table 70. Pfizer Company Information
Table 71. Pfizer Business Overview
Table 72. Pfizer Revenue in OTC Anti-Infective Medications Business (2021-2026) & (US$ Million)
Table 73. Pfizer OTC Anti-Infective Medications Product Portfolio
Table 74. Pfizer Recent Developments
Table 75. GlaxoSmithKline Company Information
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Revenue in OTC Anti-Infective Medications Business (2021-2026) & (US$ Million)
Table 78. GlaxoSmithKline OTC Anti-Infective Medications Product Portfolio
Table 79. GlaxoSmithKline Recent Developments
Table 80. Optimer Pharmaceuticals Company Information
Table 81. Optimer Pharmaceuticals Business Overview
Table 82. Optimer Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2021-2026) & (US$ Million)
Table 83. Optimer Pharmaceuticals OTC Anti-Infective Medications Product Portfolio
Table 84. Optimer Pharmaceuticals Recent Developments
Table 85. Novabay Pharmaceuticals Company Information
Table 86. Novabay Pharmaceuticals Business Overview
Table 87. Novabay Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2021-2026) & (US$ Million)
Table 88. Novabay Pharmaceuticals OTC Anti-Infective Medications Product Portfolio
Table 89. Novabay Pharmaceuticals Recent Developments
Table 90. NanoViricides Company Information
Table 91. NanoViricides Business Overview
Table 92. NanoViricides Revenue in OTC Anti-Infective Medications Business (2021-2026) & (US$ Million)
Table 93. NanoViricides OTC Anti-Infective Medications Product Portfolio
Table 94. NanoViricides Recent Developments
Table 95. MerLion Pharma Company Information
Table 96. MerLion Pharma Business Overview
Table 97. MerLion Pharma Revenue in OTC Anti-Infective Medications Business (2021-2026) & (US$ Million)
Table 98. MerLion Pharma OTC Anti-Infective Medications Product Portfolio
Table 99. MerLion Pharma Recent Developments
Table 100. Bristol-Myers Squibb Company Information
Table 101. Bristol-Myers Squibb Business Overview
Table 102. Bristol-Myers Squibb Revenue in OTC Anti-Infective Medications Business (2021-2026) & (US$ Million)
Table 103. Bristol-Myers Squibb OTC Anti-Infective Medications Product Portfolio
Table 104. Bristol-Myers Squibb Recent Developments
Table 105. Basilea Pharmaceutica Company Information
Table 106. Basilea Pharmaceutica Business Overview
Table 107. Basilea Pharmaceutica Revenue in OTC Anti-Infective Medications Business (2021-2026) & (US$ Million)
Table 108. Basilea Pharmaceutica OTC Anti-Infective Medications Product Portfolio
Table 109. Basilea Pharmaceutica Recent Developments
Table 110. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. OTC Anti-Infective Medications Product Image
Figure 5. Global OTC Anti-Infective Medications Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global OTC Anti-Infective Medications Market Share by Type: 2025 VS 2032
Figure 7. Antiseptic Product
Figure 8. Antiparasitics Product
Figure 9. Antifungals Product
Figure 10. Global OTC Anti-Infective Medications Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 11. Global OTC Anti-Infective Medications Market Share by Application: 2025 VS 2032
Figure 12. E-Commerce Product
Figure 13. Drug Stores Product
Figure 14. Hospital Pharmacies Product
Figure 15. Global OTC Anti-Infective Medications Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 16. Global OTC Anti-Infective Medications Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 17. Global OTC Anti-Infective Medications Market Share by Region: 2025 VS 2032
Figure 18. Global OTC Anti-Infective Medications Market Share by Players in 2025
Figure 19. Global OTC Anti-Infective Medications Manufacturers Established Date
Figure 20. Global Top 5 and 10 OTC Anti-Infective Medications Players Market Share by Revenue in 2025
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 22. North America OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 23. North America OTC Anti-Infective Medications Market Share by Country (2021-2032)
Figure 24. United States OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. Canada OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 26. Mexico OTC Anti-Infective Medications Market Share by Country (2021-2032)
Figure 27. Europe OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Europe OTC Anti-Infective Medications Market Share by Country (2021-2032)
Figure 29. Germany OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. France OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. U.K. OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. Italy OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Spain OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Russia OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Netherlands OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Nordic Countries OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Asia-Pacific OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Asia-Pacific OTC Anti-Infective Medications Market Share by Country (2021-2032)
Figure 39. China OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Japan OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. South Korea OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. India OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. India OTC Anti-Infective Medications Market Share by Country (2021-2032)
Figure 44. Australia OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. China Taiwan OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. Southeast Asia OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. South America OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. South America OTC Anti-Infective Medications Market Share by Country (2021-2032)
Figure 49. Brazil OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. Argentina OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Chile OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Colombia OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Peru OTC Anti-Infective Medications Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Abbott Revenue Growth Rate in OTC Anti-Infective Medications Business (2021-2026)
Figure 55. Sanofi Revenue Growth Rate in OTC Anti-Infective Medications Business (2021-2026)
Figure 56. Novartis Revenue Growth Rate in OTC Anti-Infective Medications Business (2021-2026)
Figure 57. Merck Revenue Growth Rate in OTC Anti-Infective Medications Business (2021-2026)
Figure 58. Roche Revenue Growth Rate in OTC Anti-Infective Medications Business (2021-2026)
Figure 59. Pfizer Revenue Growth Rate in OTC Anti-Infective Medications Business (2021-2026)
Figure 60. GlaxoSmithKline Revenue Growth Rate in OTC Anti-Infective Medications Business (2021-2026)
Figure 61. Optimer Pharmaceuticals Revenue Growth Rate in OTC Anti-Infective Medications Business (2021-2026)
Figure 62. Novabay Pharmaceuticals Revenue Growth Rate in OTC Anti-Infective Medications Business (2021-2026)
Figure 63. NanoViricides Revenue Growth Rate in OTC Anti-Infective Medications Business (2021-2026)
Figure 64. MerLion Pharma Revenue Growth Rate in OTC Anti-Infective Medications Business (2021-2026)
Figure 65. Bristol-Myers Squibb Revenue Growth Rate in OTC Anti-Infective Medications Business (2021-2026)
Figure 66. Basilea Pharmaceutica Revenue Growth Rate in OTC Anti-Infective Medications Business (2021-2026)
提及公司
AbbottSanofiNovartisMerckRochePfizerGlaxoSmithKlineOptimer PharmaceuticalsNovabay PharmaceuticalsNanoViricidesMerLion PharmaBristol-Myers SquibbBasilea Pharmaceutica
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們